2023 Annual Meeting | C149 - Recognizing Complications of Immunomodulation in Neurology Patients

Date Tuesday 04/25/23

Time 03:30 PM - 05:30 PM EST Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Benjamin M. Greenberg, MD, FAAN

Topic(s) Multiple Sclerosis

Learning Objectives Participants will become familiar with recognizing the various potential complications of ummunomodulation in neurologic patients and be able to appraise the risk of therapy and execute assessments to ensure safety of patients.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Quality Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic, Audience Participation

Event Timeline
03:30 PM - 03:45 PM EST	Introduction	Introduction to Course Benjamin M. Greenberg, MD, FAAN
03:45 PM - 04:30 PM EST	Speaker	Complications of Cytotoxic Immunotherapies Benjamin M. Greenberg, MD, FAAN
04:30 PM - 05:15 PM EST	Speaker	Complications of Immunomodulatory Therapies Joseph R. Berger, MD, FAAN
05:15 PM - 05:30 PM EST	Discussion	Question and Answers Benjamin M. Greenberg, MD, FAAN, Joseph R. Berger, MD, FAAN

Faculty Disclosures
Benjamin M. Greenberg, MD, FAAN	Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/ROche. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Clene. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Greenberg has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Siegel Rare Neuroimmune Association. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Carlton Fields. Dr. Greenberg has stock in GenrAb. Dr. Greenberg has stock in Clene. The institution of Dr. Greenberg has received research support from Anokion. The institution of Dr. Greenberg has received research support from Regeneron. Dr. Greenberg has received intellectual property interests from a discovery or technology relating to health care. Dr. Greenberg has received publishing royalties from a publication relating to health care.
Joseph R. Berger, MD, FAAN	Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb/Celgene. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono/Merck. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen/J&J. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Morphic. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuVIR. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seagen. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cellevolve. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MAPI. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ExcisionBio. Dr. Berger has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for WebMD. The institution of Dr. Berger has received research support from Biogen. The institution of Dr. Berger has received research support from Genentech/Roche.